Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1936 1
1939 2
1940 1
1941 1
1944 1
1945 2
1946 8
1947 6
1948 7
1949 7
1950 6
1951 17
1952 10
1953 17
1954 18
1955 17
1956 11
1957 10
1958 21
1959 16
1960 14
1961 13
1962 16
1963 19
1964 24
1965 15
1966 8
1967 4
1968 9
1969 5
1970 11
1971 11
1972 8
1973 14
1974 17
1975 45
1976 47
1977 54
1978 64
1979 95
1980 110
1981 161
1982 264
1983 319
1984 414
1985 610
1986 817
1987 858
1988 974
1989 1349
1990 1361
1991 1463
1992 1561
1993 1655
1994 2046
1995 2085
1996 2451
1997 2645
1998 2800
1999 2821
2000 3258
2001 3368
2002 3642
2003 3693
2004 4335
2005 4649
2006 5097
2007 5227
2008 5584
2009 6062
2010 6896
2011 7380
2012 8197
2013 8772
2014 9436
2015 9910
2016 10292
2017 11003
2018 11522
2019 12375
2020 14221
2021 15855
2022 16301
2023 17026
2024 8727
2025 11

Text availability

Article attribute

Article type

Publication date

Search Results

216,433 results

Results by year

Filters applied: . Clear all
Page 1
Alzheimer's disease.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Scheltens P, et al. Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2. Lancet. 2021. PMID: 33667416 Free PMC article. Review.
In this Seminar, we highlight the main developments in the field of Alzheimer's disease. The most recent data indicate that, by 2050, the prevalence of dementia will double in Europe and triple worldwide, and that estimate is 3 times higher when based on a bi …
In this Seminar, we highlight the main developments in the field of Alzheimer's disease. The most recent data indicate …
Alzheimer's disease.
Lane CA, Hardy J, Schott JM. Lane CA, et al. Eur J Neurol. 2018 Jan;25(1):59-70. doi: 10.1111/ene.13439. Epub 2017 Oct 19. Eur J Neurol. 2018. PMID: 28872215 Review.
Alzheimer's disease, the commonest cause of dementia, is a growing global health concern with huge implications for individuals and society. In this review, current understanding of the epidemiology, genetics, pathology and pathogenesis of Alzheimer' …
Alzheimer's disease, the commonest cause of dementia, is a growing global health concern with huge implications for ind …
Current understanding of Alzheimer's disease diagnosis and treatment.
Weller J, Budson A. Weller J, et al. F1000Res. 2018 Jul 31;7:F1000 Faculty Rev-1161. doi: 10.12688/f1000research.14506.1. eCollection 2018. F1000Res. 2018. PMID: 30135715 Free PMC article. Review.
Alzheimer's disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. ...Here, we discuss recent advances in our understanding of the clinical evaluation and treatment of A …
Alzheimer's disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part beca …
Alzheimer's disease.
Soria Lopez JA, González HM, Léger GC. Soria Lopez JA, et al. Handb Clin Neurol. 2019;167:231-255. doi: 10.1016/B978-0-12-804766-8.00013-3. Handb Clin Neurol. 2019. PMID: 31753135 Review.
Alzheimer's disease (AD) dementia refers to a particular onset and course of cognitive and functional decline associated with age together with a particular neuropathology. ...Alzheimer's disease is now the most common form of neurodegene …
Alzheimer's disease (AD) dementia refers to a particular onset and course of cognitive and functional decline associate …
Alzheimer's Disease: Past, Present, and Future.
Bondi MW, Edmonds EC, Salmon DP. Bondi MW, et al. J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X. J Int Neuropsychol Soc. 2017. PMID: 29198280 Free PMC article. Review.
." - Old Testament: Sirach 3:12), our knowledge of its underlying causes is little more than a century old. Alzheimer published his now famous case study only 110 years ago, and our modern understanding of the disease that bears his name, and its neuropsychological …
." - Old Testament: Sirach 3:12), our knowledge of its underlying causes is little more than a century old. Alzheimer published his n …
New insights into atypical Alzheimer's disease in the era of biomarkers.
Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME. Graff-Radford J, et al. Lancet Neurol. 2021 Mar;20(3):222-234. doi: 10.1016/S1474-4422(20)30440-3. Lancet Neurol. 2021. PMID: 33609479 Free PMC article. Review.
In the past, these individuals often received a late diagnosis; however, availability of CSF and PET biomarkers of Alzheimer's disease pathologies and incorporation of atypical forms of Alzheimer's disease into new diagnostic criteria inc …
In the past, these individuals often received a late diagnosis; however, availability of CSF and PET biomarkers of Alzheimer's …
Pathogenesis of Alzheimer's Disease.
Rostagno AA. Rostagno AA. Int J Mol Sci. 2022 Dec 21;24(1):107. doi: 10.3390/ijms24010107. Int J Mol Sci. 2022. PMID: 36613544 Free PMC article.
Alzheimer's disease (AD) is the most common type of dementia, accounting for 60% to 80% of all cases [...]....
Alzheimer's disease (AD) is the most common type of dementia, accounting for 60% to 80% of all cases [...]....
Biomarkers for Alzheimer's Disease Diagnosis.
Mantzavinos V, Alexiou A. Mantzavinos V, et al. Curr Alzheimer Res. 2017;14(11):1149-1154. doi: 10.2174/1567205014666170203125942. Curr Alzheimer Res. 2017. PMID: 28164766 Free PMC article. Review.
OBJECTIVE: The dramatic increase in the population with dementia expected in the next decades is accompanied by the establishment of novel and innovated methods that will offer accurate and efficient detection of the disease in its early stages. While Alzheimer's …
OBJECTIVE: The dramatic increase in the population with dementia expected in the next decades is accompanied by the establishment of novel a …
Drug treatments in Alzheimer's disease.
Briggs R, Kennelly SP, O'Neill D. Briggs R, et al. Clin Med (Lond). 2016 Jun;16(3):247-53. doi: 10.7861/clinmedicine.16-3-247. Clin Med (Lond). 2016. PMID: 27251914 Free PMC article. Review.
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease. Studies of potential disease-m …
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's …
[Alzheimer's disease - diagnosis and treatment].
Knapskog AB, Engedal K, Selbæk G, Øksengård AR. Knapskog AB, et al. Tidsskr Nor Laegeforen. 2021 Apr 29;141(7). doi: 10.4045/tidsskr.20.0919. Print 2021 May 4. Tidsskr Nor Laegeforen. 2021. PMID: 33950641 Free article. Norwegian.
Alzheimer's disease is the most common cause of dementia globally. Its prevalence will increase considerably in the years to come, in pace with the increasing proportion of older people. No disease-modifying treatment is currently available. Measures t …
Alzheimer's disease is the most common cause of dementia globally. Its prevalence will increase considerably in the yea …
216,433 results
You have reached the last available page of results. Please see the User Guide for more information.